Wei, Qiaozhi
Pinho, Sandra http://orcid.org/0000-0002-5241-7364
Dong, Shuxian http://orcid.org/0000-0003-4725-8482
Pierce, Halley
Li, Huihui
Nakahara, Fumio
Xu, Jianing
Xu, Chunliang
Boulais, Philip E.
Zhang, Dachuan http://orcid.org/0000-0002-1746-275X
Maryanovich, Maria http://orcid.org/0000-0002-2015-0538
Cuervo, Ana Maria http://orcid.org/0000-0002-0771-700X
Frenette, Paul S. http://orcid.org/0000-0003-0862-9922
Article History
Received: 6 December 2020
Accepted: 22 March 2021
First Online: 4 May 2021
Competing interests
: Q.W. and P.S.F. are co-inventors on a patent application using anti-MAEA antibodies (W02017205560A1). P.S.F. serves as consultant for Pfizer, has received research funding from Ironwood Pharmaceuticals and is shareholder of Cygnal Therapeutics. A.M.C. is co-founder of Selphagy Therapeutics. The other authors declare no competing interests.